IMDEVIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 07:08:48 GMT 2025` Edited by `admin` on `Wed Apr 02 07:08:48 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	2Z3DQD2JHM
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

IMDEVIMAB

Official Name

English

REGN-10987

Preferred Name

English

IMDEVIMAB [JAN]

Common Name

English

Imdevimab [WHO-DD]

Common Name

English

imdevimab [INN]

Common Name

English

REGN10987

Code

English

IMDEVIMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL REGN10987 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN10987 .LAMBDA.-CHAIN, DIMER

Common Name

English

Code System Code Type Description

CAS

2415933-40-1

Created by admin on Wed Apr 02 07:08:48 GMT 2025 , Edited by admin on Wed Apr 02 07:08:48 GMT 2025

PRIMARY

RXCUI

2465249

Created by admin on Wed Apr 02 07:08:48 GMT 2025 , Edited by admin on Wed Apr 02 07:08:48 GMT 2025

PRIMARY

LACTMED

Imdevimab

Created by admin on Wed Apr 02 07:08:48 GMT 2025 , Edited by admin on Wed Apr 02 07:08:48 GMT 2025

PRIMARY

SMS_ID

300000023253

Created by admin on Wed Apr 02 07:08:48 GMT 2025 , Edited by admin on Wed Apr 02 07:08:48 GMT 2025

PRIMARY

FDA UNII

2Z3DQD2JHM

Created by admin on Wed Apr 02 07:08:48 GMT 2025 , Edited by admin on Wed Apr 02 07:08:48 GMT 2025

PRIMARY

USAN

HI-238

Created by admin on Wed Apr 02 07:08:48 GMT 2025 , Edited by admin on Wed Apr 02 07:08:48 GMT 2025

PRIMARY

INN

11863

Created by admin on Wed Apr 02 07:08:48 GMT 2025 , Edited by admin on Wed Apr 02 07:08:48 GMT 2025

PRIMARY

NCI_THESAURUS

C177063

Created by admin on Wed Apr 02 07:08:48 GMT 2025 , Edited by admin on Wed Apr 02 07:08:48 GMT 2025

PRIMARY

DAILYMED

2Z3DQD2JHM

Created by admin on Wed Apr 02 07:08:48 GMT 2025 , Edited by admin on Wed Apr 02 07:08:48 GMT 2025

PRIMARY

From	To
4_138	4_197
4_22	4_90
3_138	3_197
3_22	3_90
2_370	2_428
2_264	2_324
2_223	4_215
2_147	2_203
2_22	2_96
1_370	1_428
1_264	1_324
1_232	2_232
1_229	2_229
1_223	3_215
1_147	1_203
1_22	1_96

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_300
N	2_300

Related Record Type Details


					2Z3DQD2JHM

IMDEVIMAB

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION	[1_1] [2_1] [3_1] [4_1]	N-TERMINUS			PIDOLIC ACID	SZB83O1W42
AMINO ACID REMOVAL	[1_450] [2_450]				LYSINE	K3Z4F929H6

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL